newsfilter
← Earnings
Earnings Releases·

IRADIMED CORPORATION — Third Quarter 2026 Earnings Summary

IRADIMED Corporation reported third-quarter 2026 revenue of $24.2 million, representing a 14% increase from the same period in 2025, driven by the successful launch of its new 3870 MR IV pump. The company recorded GAAP diluted earnings per share of $0.51 and non-GAAP diluted earnings per share of $0.55 for the quarter. Additionally, the board declared a regular quarterly cash dividend of $0.20 per share, payable on November 27, 2026. Management revised its full-year 2026 revenue guidance to a range of $91.6 million to $93.1 million and expects fourth-quarter revenue to fall between $25.0 million and $26.5 million.

Company
IRADIMED CORP
Sector
Healthcare
Industry
Medical Devices